IN PATIENTS WITH DIFFERENT FORMS OF OSTEOPOROSIS EXCELLENT ADHERENCE TO 6-MONTHLY DENOSUMAB INJECTIONS CAN BE ACHIEVED BY POSITIVE FEEDBACK BASED ON 6 AND 12 MONTHS BMD INCREASES AND RARE ADVERSE EVEN